Functional interaction of intestinal CYP3A4 and P-glycoprotein.
about
Impact of the herbal medicine Sophora flavescens on the oral pharmacokinetics of indinavir in rats: the involvement of CYP3A and P-glycoproteinIncorporation of ABCB1-mediated transport into a physiologically-based pharmacokinetic model of docetaxel in mice.Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp.Drug interactions in cancer therapy.Heme in intestinal epithelial cell turnover, differentiation, detoxification, inflammation, carcinogenesis, absorption and motility.Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone.Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety.The grapefruit: an old wine in a new glass? Metabolic and cardiovascular perspectives.Role of multidrug transporters in neurotherapeuticsNovel oral anticoagulants and their role in clinical practice.Drug interactions: a primer for the gastroenterologistCytochrome P450-mediated changes in oxycodone pharmacokinetics/pharmacodynamics and their clinical implications.Transporter-mediated drug-drug interactions with oral antidiabetic drugs.Down-regulation of hepatic CYP3A1 expression in a rat model of indomethacin-induced small intestinal ulcers.Simultaneous evaluation of human CYP3A4 and ABCB1 induction by reporter assay in LS174T cells, stably expressing their reporter genes.P-gp activity and inhibition in the different regions of human intestine ex vivo.Intestinal drug transporter expression and the impact of grapefruit juice in humans.Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment from in vitro studies and a clinical investigation with midazolam.Effects of Gingko biloba extract on tissue distribution of fluoxetine and venlafaxine in rats.Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir.Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation.Pharmacokinetic interaction between ketoconazole and praziquantel in healthy volunteers.Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin.Effect of itraconazole on the pharmacokinetics of atenolol.Modulation of human cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) in Caco-2 cell monolayers by selected commercial-source milk thistle and goldenseal products.Expression of P-glycoprotein and CYP3A4 along the porcine oral-gastrointestinal tract: implications on oral mucosal drug delivery.Itraconazole, a P-Glycoprotein and CYP3A4 Inhibitor, Markedly Raises the Plasma Concentrations and Enhances the Renin-Inhibiting Effect of Aliskiren
P2860
Q28480909-22D94CEE-2629-4560-8922-CB312CBBD673Q34937463-EF7F5E67-69DE-44F7-81CB-C86F89C44067Q35852614-081513D1-D0C1-45D1-8229-68C79F3C92C6Q36516421-7C3D12D0-EFE8-4514-98A9-7260C89884C3Q36545940-FD781324-44CF-475E-BD4A-D70357B88B71Q36856634-6D3EBFD9-598F-40DD-99A2-1BC42888A6FBQ36960535-42C97F9E-9FCD-4236-B5E8-40B12DCA6A05Q37041734-062D60B9-6A36-41CE-B0E3-045DD6D4F391Q37689499-ACE8FCCA-D45A-4A4E-A109-2ACEE3B0F8CEQ37961824-C0763220-1240-4629-8308-A882943E4541Q38039067-A4AAE530-C5E5-40F2-995F-73F01CFE9BF7Q38100710-05F9C0CD-0354-4437-B363-40FD9F7B1774Q38168993-8B4AB90A-2F98-49A2-8F6A-3B76A029037FQ38743869-B6B409B2-7F2F-4CCB-AC79-097DD74728F0Q38939091-5962D2CD-EF54-4581-A3AC-57D401A2E0ECQ39272976-6191743C-75E9-4743-82D8-3831F7C55A54Q40184411-013BF62D-3B53-474C-8D2D-56C14FEF9B77Q41015337-2687C39E-6D3F-4453-82CB-18F055603C69Q41917427-A5CA32CB-9EBD-4643-9A8E-99BD4D485FD9Q42429561-2B1A2742-8B3A-45A7-9B84-4D08F395D2D6Q42440768-F5B16792-83A3-4159-B222-6DD481241487Q42637287-602C4655-3E72-49C9-AAC3-477388E9CAA4Q43258273-D4566B40-B4FF-427B-867D-B65846E4E097Q46858396-87967041-B97A-4384-A7E8-33B9236E51A2Q46861103-1BF413A7-998F-445F-A15F-AA06F9112942Q51742193-F6BA7C8C-28AA-4F68-8769-FF3D7CEEC583Q57825127-1C9F4912-A615-4564-8B44-BAA3DC98AFBC
P2860
Functional interaction of intestinal CYP3A4 and P-glycoprotein.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Functional interaction of intestinal CYP3A4 and P-glycoprotein.
@ast
Functional interaction of intestinal CYP3A4 and P-glycoprotein.
@en
type
label
Functional interaction of intestinal CYP3A4 and P-glycoprotein.
@ast
Functional interaction of intestinal CYP3A4 and P-glycoprotein.
@en
prefLabel
Functional interaction of intestinal CYP3A4 and P-glycoprotein.
@ast
Functional interaction of intestinal CYP3A4 and P-glycoprotein.
@en
P2860
P1476
Functional interaction of intestinal CYP3A4 and P-glycoprotein.
@en
P2093
Kari T Kivistö
Martin F Fromm
P2860
P304
P356
10.1111/J.1472-8206.2004.00291.X
P50
P577
2004-12-01T00:00:00Z